NYSCF and eagle-i Network co-develop iPS cell database

By Sykes24Tracey

PUBLIC RELEASE DATE:

19-Jun-2014

Contact: David McKeon DMcKeon@nyscf.org 212-365-7440 New York Stem Cell Foundation

NEW YORK, NY (June 18, 2014) Induced Pluripotent Stem Cells (iPS) hold enormous potential to unravel the mechanisms of human illness and to develop new therapeutics. Until now, there has been no easily searchable database for investigators to find and share these important resources. This has been a major obstacle to the implementation of iPS technology.

Recognizing the research potential of shared iPS cell lines, the New York Stem Cell Foundation (NYSCF) Research Institute and the eagle-i Network will make NYSCF iPS cell lines and related information available to the public on a user-friendly, web-based, searchable database. The database (called the Induced Pluripotent Stem Cell database) will help scientists find valuable resources, enabling collaboration, preventing duplicative work, and ultimately accelerating research.

NYSCF and eagle-i will establish an open access repository of information on large numbers of iPS cell lines. eagle-i will display information as linked open data, enabling discovery by any third party search engine. NYSCF derives hundreds of iPS cell lines from skin samples of patients with a wide variety of diseases using the NYSCF Global Stem Cell ArrayTM technology, an automated platform for high-throughput iPS cell production and differentiation. Scientists will be able to search for NYSCF iPS cell lines under several categories including disease, how the cells were reprogrammed, and patient age at the time the sample was collected.

"This important tool should have significant impact on the science community," said Lee Nadler, principal investigator of Harvard Catalyst and eagle-i. "I'm thrilled that we will contribute to this partnership by creating a user-friendly, searchable database for the iPS cell lines that NYSCF has produced, enabling researchers to search for available lines on an open access platform. The opportunities this will create are tremendous."

"We were very excited to develop this resource for stem cell scientists," said Susan L. Solomon, NYSCF Chief Executive Officer. "It is important to have open access to available resources and this collaboration with eagle-i is a prime example of interdisciplinary teams working together to provide this for the scientific community."

The alpha version of the website will be presented during the International Society for Stem Cell Research (ISSCR) Annual Conference in Vancouver, Canada in June 2014. Future versions of the database will include genomic and other clinical and cellular phenotype information, including a mechanism that will allow scientists to order lines directly from the website. Soon, NYSCF and eagle-i will invite other institutions from around the world to join this collaboration and contribute their iPS cell lines to the Induced Pluripotent Stem Cell database, creating an even more robust research tool.

At the ISSCR Conference this week, Richard V. Pearse, PhD, from eagle-i will be at poster F-2245 during poster session III and NYSCF will be at booth 918 with information pertaining to this new initiative.

View post:
NYSCF and eagle-i Network co-develop iPS cell database

Related Post


categoriaSkin Stem Cells commentoComments Off on NYSCF and eagle-i Network co-develop iPS cell database | dataJune 30th, 2014

About...

This author published 794 posts in this site.
Just for fun

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2024